TRIL: Key Regulator of Immune Response and Disease (G9865)

Target Name: TRIL

NCBI ID: G9865

TRIL

TRIL: Key Regulator of Immune Response and Disease

TRIL (TLR4 interactor with leucine rich repeats) is a protein that is expressed in various tissues and cells throughout the body. It is a key regulator of the innate immune response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the unique features of TRIL is its ability to interact with leucine rich repeats, which are a type of protein that is often found in the immune response. These repeats are thought to play a role in the regulation of TRIL expression and its function in the immune response.

TRIL has been shown to play a key role in the regulation of T cell responses, which are a critical part of the immune system. T cells are responsible for recognizing and responding to foreign substances in the body, and their activity is regulated by TRIL.

In addition to its role in T cell regulation, TRIL has also been shown to play a key role in the regulation of inflammation. Inflammation is a natural response of the immune system to injury or infection, and it can be a contributing factor to a number of diseases, including cancer and neurodegenerative diseases.

TRIL has been shown to be involved in the regulation of inflammation by promoting the production of pro-inflammatory cytokines. These cytokines, which are a key part of the immune response, can contribute to the development and progression of inflammatory diseases.

Another key function of TRIL is its role in the regulation of cell survival. TRIL has been shown to play a key role in the regulation of cell cycle progression, which is the process by which cells divide and grow. This regulation is important for the survival and proliferation of cells, and is a potential target for cancer therapies.

TRIL has also been shown to play a key role in the regulation of gene expression. This is the process by which cells express the instructions for building the proteins that are involved in many cellular processes. TRIL has been shown to interact with a variety of transcription factors, which are proteins that help to regulate gene expression.

In conclusion, TRIL is a protein that has important roles in the regulation of the innate immune response, inflammation, cell survival, and gene expression. Its unique ability to interact with leucine rich repeats makes it a potential drug target and a promising biomarker for a variety of diseases. Further research is needed to fully understand the functions of TRIL and its potential as a drug.

Protein Name: TLR4 Interactor With Leucine Rich Repeats

Functions: Component of the TLR4 signaling complex. Mediates the innate immune response to bacterial lipopolysaccharide (LPS) leading to cytokine secretion

The "TRIL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRIL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets